GB1507521A - Dosage unit - Google Patents

Dosage unit

Info

Publication number
GB1507521A
GB1507521A GB10214/75A GB1021475A GB1507521A GB 1507521 A GB1507521 A GB 1507521A GB 10214/75 A GB10214/75 A GB 10214/75A GB 1021475 A GB1021475 A GB 1021475A GB 1507521 A GB1507521 A GB 1507521A
Authority
GB
United Kingdom
Prior art keywords
active ingredient
coat
sugar
cellulose
dosage units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10214/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of GB1507521A publication Critical patent/GB1507521A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB10214/75A 1974-03-12 1975-03-12 Dosage unit Expired GB1507521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (https=) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
GB1507521A true GB1507521A (en) 1978-04-19

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10214/75A Expired GB1507521A (en) 1974-03-12 1975-03-12 Dosage unit

Country Status (12)

Country Link
US (1) US3976764A (https=)
JP (1) JPS5512411B2 (https=)
BE (1) BE826498A (https=)
CA (1) CA1054056A (https=)
CH (1) CH604719A5 (https=)
DE (1) DE2510620C2 (https=)
DK (1) DK142802B (https=)
ES (1) ES435500A1 (https=)
FR (1) FR2263744B1 (https=)
GB (1) GB1507521A (https=)
NL (1) NL7502952A (https=)
SE (1) SE409286B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0106202A3 (en) * 1982-09-20 1985-05-02 Fujisawa Pharmaceutical Co., Ltd. New type soft capsule
US6284271B1 (en) 1997-07-01 2001-09-04 Astrazeneca Ab Multiple unit effervescent dosage form
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
JPS58501128A (ja) * 1981-07-15 1983-07-14 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 徐放性テオフイリン
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (https=) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
WO1992000066A1 (en) * 1990-06-25 1992-01-09 The Du Pont Merck Pharmaceutical Company Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
IN186245B (https=) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
EP1063973B1 (en) 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
EA011215B1 (ru) * 2003-02-21 2009-02-27 Лек Фармасьютиклз Д.Д. Терапевтическая система, содержащая амоксициллин и клавулановую кислоту, плавающая капсула
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
CA2661172A1 (en) * 2006-09-04 2008-05-29 Panacea Biotec Limited Programmable buoyant delivery technology
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2460915B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
EP2329810A4 (en) * 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
CA2767143A1 (en) * 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Tablet having hollow structure
CA2803064C (en) 2010-07-05 2017-12-19 Jagotec Ag Dosage form
WO2014014348A1 (en) * 2012-07-16 2014-01-23 APET Holding B.V. Gastro-retentive drug delivery system
CA2841731A1 (en) * 2011-07-14 2013-01-17 Hendrik Jan Cornelis Meijerink Nicotinamide compositions and the therapeutic use thereof
CA2851765C (en) 2011-10-11 2017-08-15 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2015191922A1 (en) 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Enteric elastomers
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CA2983272C (en) 2015-05-01 2023-08-29 Massachusetts Institute Of Technology Triggerable shape memory induction devices
HK1258050A1 (zh) 2015-10-23 2019-11-01 Lyndra Therapeutics, Inc. 用於治疗剂缓释的胃驻留系统及其使用方法
EP3386488B1 (en) 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
AU2017235598A1 (en) * 2016-03-18 2018-08-09 Grünenthal GmbH Floating pharmaceutical dosage form
AU2017268840B2 (en) 2016-05-27 2022-02-10 Nortiva Bio, Inc. Materials architecture for gastric residence systems
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
JP7624750B2 (ja) * 2020-03-02 2025-01-31 クラフト ヘルス プライベート リミテッド 持続的薬物放出のための経口剤形
EP4008509B1 (de) * 2020-10-14 2023-06-07 Bichsel, Hannes Geschäumte biogranulatkörner

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0106202A3 (en) * 1982-09-20 1985-05-02 Fujisawa Pharmaceutical Co., Ltd. New type soft capsule
US6284271B1 (en) 1997-07-01 2001-09-04 Astrazeneca Ab Multiple unit effervescent dosage form
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Also Published As

Publication number Publication date
JPS5512411B2 (https=) 1980-04-02
ES435500A1 (es) 1977-02-01
US3976764A (en) 1976-08-24
DE2510620C2 (de) 1984-01-05
DK97875A (https=) 1975-09-13
FR2263744A1 (https=) 1975-10-10
CA1054056A (en) 1979-05-08
DK142802B (da) 1981-02-02
CH604719A5 (https=) 1978-09-15
SE409286B (sv) 1979-08-13
FR2263744B1 (https=) 1978-11-24
SE7502725L (https=) 1975-09-15
BE826498A (fr) 1975-06-30
DK142802C (https=) 1981-09-21
DE2510620A1 (de) 1975-09-18
NL7502952A (nl) 1975-09-16
JPS50121418A (https=) 1975-09-23

Similar Documents

Publication Publication Date Title
GB1507521A (en) Dosage unit
TW420616B (en) Controlled-release dosage forms of azithromycin
KR910004578B1 (ko) 위내 체류형 과립의 제조방법
IE45578L (en) Propranolol capsules
US5540945A (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
GB1161439A (en) Pharmaceutical Compositions
EP0014253A2 (en) Simethicone antacid tablet
JPS5959633A (ja) 放出調整複合単位組成物の製法
CA2132012A1 (en) Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
GB2101485A (en) Delayed-release pharmaceutical compositions of bromhexine
JPH0772130B2 (ja) 持続性製剤
ES388698A1 (es) Procedimiento para la preparacion de pequenas bolitas medi-camentosas para administracion oral con un revestimiento re-tardador de la liberacion de sustancia activa.
CA2183862A1 (en) Stabilized composition for oral administration of peptides
GB2176704A (en) Solid, stable dosage forms with an elastic film coating
DE3680866D1 (de) Herstellungsverfahren fuer arzneimittel mit verzoegerter wirkstoffabgabe.
EP0425699A1 (en) Oral preparation which can be released at suitable region in intestine
JPH02504145A (ja) 酵素制御薬物放出性ペレット
JPH02164821A (ja) 新規な投与形態
IT8467131A1 (it) Preparazione farmaceutica a base di n"-ciano-n-4-piridil-n'-1,2,2-trimetilpropilguanidina, particolarmente per il trattamento dell'ipertensione.
JPH09504779A (ja) α−アドレノリセプタ遮断剤用薬剤移送組成物
US3696188A (en) Laminated tablets
JPH0260643B2 (https=)
GB1458676A (en) Orally administrable corticosteroid preparations
GB1276089A (en) Pharmaceutical preparations
GB793808A (en) Sustained action pill

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930312